| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |